- Home
- FEMY vs COCH Comparison
FEMY vs COCH Comparison
Compare FEMY & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- COCH
- Stock Information
- Founded
- FEMY 2004
- COCH 1995
- Country
- FEMY United States
- COCH United States
- Employees
- FEMY N/A
- COCH N/A
- Industry
- FEMY Medical/Dental Instruments
- COCH Blank Checks
- Sector
- FEMY Health Care
- COCH Finance
- Exchange
- FEMY Nasdaq
- COCH Nasdaq
- Market Cap
- FEMY 29.9M
- COCH 31.6M
- IPO Year
- FEMY 2021
- COCH N/A
- Fundamental
- Price
- FEMY $0.84
- COCH $1.53
- Analyst Decision
- FEMY Strong Buy
- COCH Strong Buy
- Analyst Count
- FEMY 3
- COCH 2
- Target Price
- FEMY $8.67
- COCH $9.25
- AVG Volume (30 Days)
- FEMY 158.0K
- COCH 28.9K
- Earning Date
- FEMY 08-07-2025
- COCH 08-11-2025
- Dividend Yield
- FEMY N/A
- COCH N/A
- EPS Growth
- FEMY N/A
- COCH N/A
- EPS
- FEMY N/A
- COCH N/A
- Revenue
- FEMY $1,699,232.00
- COCH $212,000.00
- Revenue This Year
- FEMY $283.83
- COCH $5.93
- Revenue Next Year
- FEMY $161.03
- COCH $17.69
- P/E Ratio
- FEMY N/A
- COCH N/A
- Revenue Growth
- FEMY 61.97
- COCH N/A
- 52 Week Low
- FEMY $0.69
- COCH $1.21
- 52 Week High
- FEMY $1.80
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- FEMY 37.62
- COCH 47.52
- Support Level
- FEMY $0.91
- COCH $1.60
- Resistance Level
- FEMY $0.93
- COCH $1.60
- Average True Range (ATR)
- FEMY 0.04
- COCH 0.10
- MACD
- FEMY -0.01
- COCH -0.01
- Stochastic Oscillator
- FEMY 5.12
- COCH 24.32
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.